Clinical Research Directory
Browse clinical research sites, groups, and studies.
AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention
Sponsor: Brigham and Women's Hospital
Summary
AI INFORM is a multicenter randomized trial that will test the hypothesis that providing clinicians information on the presence and amount of coronary artery calcifications (CAC), will result in initiation or intensification of preventive therapies. The study will use a cloud-based artificial intelligence (AI) platform (Nanox.AI) that can analyze non contrast chest CT and estimate the amount of CAC.
Official title: AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention: A Multicenter Randomized Trial
Key Details
Gender
All
Age Range
40 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
1500
Start Date
2024-07-31
Completion Date
2027-12-01
Last Updated
2026-01-23
Healthy Volunteers
No
Conditions
Interventions
Electronic health record-based notification of Nanox.AI Coronary Artery Calcification Assessment
The intervention involves electronic health record, email, or letter notification about the presence of coronary artery calcification on chest CT and recommendation of preventive therapy. This is based on results of the automatic detection of coronary artery calcification from AI device (software).
Locations (1)
Brigham and Women's Hospital
Boston, Massachusetts, United States